Acceleron Pharma Inc's

• XLRN's Stock Performance relative to its Competitors

Editas Medicine Inc Share Performance +2.22% Over The Past 5 Days

Editas Medicine Inc Profile Editas Medicine Inc.'s business model revolves around developing and commercializing transformative genome editing technologies to treat serious diseases. More about Editas Medicine Inc 's Market Share

Inozyme Pharma Inc Share Performance -9.30% One Year

Inozyme Pharma Inc Profile Inozyme Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing novel therapies for the treatment of rare and life-threatening mineral metabolic disorders. The company aims to leverage its expertise in the biology of enzymes and rare diseases to develop innovative therapeutics that can address the underlying cause of these disorders. Inozyme Pharma pursues partnerships and collaborations to advance their pipeline of potential therapies and bring them to market efficiently. More about Inozyme Pharma Inc 's Market Share

Keros Therapeutics Inc Share Performance +6.29% 30 Days

Keros Therapeutics Inc Profile Keros Therapeutics Inc's business model is focused on the development of therapeutics to address significant unmet needs in various diseases by targeting specific protein elements within the cell signaling pathways. More about Keros Therapeutics Inc 's Market Share

Summit Therapeutics Inc Share Performance +30.02% 30 Days

Summit Therapeutics Inc Profile Summit Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of rare diseases. The company employs a research-driven business model, leveraging its proprietary technologies and expertise to identify and develop novel drugs targeting specific genetic mutations associated with these rare diseases. Summit Therapeutics Inc aims to bring its drug candidates through preclinical and clinical development stages and ultimately secure regulatory approval and commercialize them to benefit patients in need. More about Summit Therapeutics Inc 's Market Share

Trevi Therapeutics Inc Share Performance -6.70% 30 Days

Trevi Therapeutics Inc Profile Trevi Therapeutics Inc is a biopharmaceutical company that specializes in developing therapies for neurologically mediated conditions. Their business model focuses on identifying and developing innovative treatment options that target specific receptors in the nervous system. By leveraging their expertise in neuroscience and drug development, Trevi aims to bring novel therapies to market and improve the lives of patients suffering from these conditions. More about Trevi Therapeutics Inc 's Market Share

Sources: Acceleron Pharma inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, September 7, 2026 5:23 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Acceleron Pharma inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.